New York · 2025-2026 session
Status: In committee
Requires health plan coverage to include generic drugs and biosimilars where the wholesale acquisition cost of such generic drugs or biosimilars is lower than the brand drug's wholesale acquisition cost.
REFERRED TO INSURANCE (2026-05-04)